Table 1.
Baseline Characteristics of Patients According to Quartiles of Triglyceride/HDL Ratio
| Variables | Triglyceride/HDL Ratio Quartiles | P for Trend | |||
|---|---|---|---|---|---|
| Q1 (n=225) | Q2 (n=224) | Q3 (n=227) | Q4 (n=224) | ||
| Age, y | 58.0±12.6 | 57.7±12.6 | 58.5±13.6 | 57.4±11.7 | .813 |
| Male, No. (%) | 95 (42) | 128 (57) | 126 (56) | 139 (62) | <.001 |
| Current smoker, No. (%) | 44 (20) | 53 (24) | 51 (23) | 53 (24) | .692 |
| Diabetes mellitus, No. (%) | 28 (12) | 30 (13) | 47 (21) | 47 (21) | .017 |
| Body mass index, kg/m2 | 27.1±1.5 | 26.9±1.6 | 27.0±1.5 | 26.8±1.5 | .122 |
| Fasting glucose, mg/dL | 98 (90–110) | 97 (89–111) | 100 (91–121) | 102 (93–118) | .001 |
| eGFR, mL/min/1.73 m2 | 102 (84–131) | 100 (83–119) | 97 (77–118) | 94 (75–114) | .011 |
| Hemoglobin, g/L | 14.2±1.4 | 14.3±1.4 | 14.5±1.4 | 14.7±1.4 | .002 |
| WBC count, ×109/L | 7 (6.1–8) | 6.7 (6–8) | 7.1 (6–8.4) | 7.6 (6.6–9) | <.001 |
| HDL, mg/dL | 58.9±11.5 | 46.4±7.6 | 41.0±8.3 | 35.7±7.5 | <.001 |
| LDL, mg/dL | 126.7±26.3 | 125.8±30.2 | 124.9±26.1 | 125.6±31.5 | .944 |
| Triglycerides, mg/dL | 100.0±31.1 | 123.9±19.7 | 155.0±34.1 | 246.9±45.6 | <.001 |
| Office SBP, mm Hg | 155 (146–174) | 160 (149–172) | 160 (150–175) | 159 (149–173) | .303 |
| Office DBP, mm Hg | 99 (91–113) | 101 (91–115) | 101 (91–115) | 98 (90–114) | .747 |
| Use of antihypertensive drugs, No. (%) | 102 (45) | 79 (35) | 86 (38) | 99 (44) | .952 |
| Use of antihyperlipidemic drugs, No. (%) | |||||
| Statins | 83 (37) | 84 (38) | 96 (42) | 103 (46) | .029 |
| Fibrats | 2 (1) | 12 (5) | 27 (12) | 56 (25) | <.001 |
| Others | 0 | 0 | 0 | 0 | – |
| Total | 85 (38) | 96 (43) | 121 (53) | 148 (66) | <.001 |
| Follow up time, mo | 38.5±7.1 | 38.9±7.5 | 38.5±7.5 | 38.2±7.4 | .782 |
Abbreviations: DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; SBP, systolic blood pressure; WBC, white blood cell.